Compounded Options: Local and national pharmacies continue to provide lower-cost alternatives, though recent semaglutide news highlights a major FDA crackdown on "mass-marketed" copycat versions to ensure patient safety
While the injection is FDA-approved and supported by extensive trial data, oral versions lack the same level of verification
00:02:45 Narrator This podcast offers continuing education credit for pharmacists, pharmacy technicians, physicians, and nurses
They could do so at a significant discount because vials are cheaper to produce than the branded injectables, making them a popular option for cash-paying patients
Injectable GHK-Cu was in Category 2 the more restrictive category for substances with "significant safety concerns." Its removal from Category 2 is the more positive development, as it signals the FDA no longer considers injectable GHK-Cu to carry the safety risk level that warranted Category 2 placement